keros

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

GlobeNewswire - 06 Nov 2024
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results  ...

• More

Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023)

Yahoo Finance - 08 Nov 2024
Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023)  ...

• More

Keros shares supported by Truist’s Buy rating, noting pivotal drug differentiation

Investing.com India - 05 Nov 2024
Keros shares supported by Truist’s Buy rating, noting pivotal drug differentiation  ...

• More

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

GlobeNewswire - 06 Nov 2024
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference  ...

• More

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

StockTitan - 06 Nov 2024
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference  ...

• More

Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark

Investor's Business Daily - 05 Sep 2024
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark  ...

• More

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire - 05 Nov 2024
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition  ...

• More

Keros Therapeutics to Present Breakthrough Clinical Data at ASH 2024 Annual Meeting | KROS Stock News

StockTitan - 05 Nov 2024
Keros Therapeutics to Present Breakthrough Clinical Data at ASH 2024 Annual Meeting | KROS Stock News  ...

• More

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

StockTitan - 06 Nov 2024
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results  ...

• More

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

GlobeNewswire - 03 Sep 2024
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial  ...

• More

Keros Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire - 07 Aug 2024
Keros Therapeutics Reports Second Quarter 2024 Financial Results  ...

• More

Keros Therapeutics Presents Clinical Data from its

GlobeNewswire - 17 Jun 2024
Keros Therapeutics Presents Clinical Data from its  ...

• More

Keros Therapeutics Announces Leadership Updates

GlobeNewswire - 17 Jun 2024
Keros Therapeutics Announces Leadership Updates  ...

• More

Keros Therapeutics Announces U.S. FDA Fast Track

GlobeNewswire - 14 Mar 2024
Keros Therapeutics Announces U.S. FDA Fast Track  ...

• More

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

GlobeNewswire - 16 Oct 2024
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer  ...

• More

Keros Therapeutics to Develop KER-065 for the Treatment of Obesity

GlobeNewswire - 03 Jan 2024
Keros Therapeutics to Develop KER-065 for the Treatment of Obesity  ...

• More

Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth

Benzinga - 25 Jun 2024
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth  ...

• More

KROS - Keros Therapeutics, Inc. Latest Stock News & Market Updates

StockTitan - 06 Nov 2024
KROS - Keros Therapeutics, Inc. Latest Stock News & Market Updates  ...

• More

Figure 1. Keros type I. LLCP = 0 to (86 sides in the study)

ResearchGate - 21 Dec 2023
Figure 1. Keros type I. LLCP = 0 to (86 sides in the study)  ...

• More